American Healthcare REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on January 19, 2022, by American Healthcare REIT, Inc. (Maryland). The filing primarily addresses the termination of existing credit facilities and the entry into a new, amended, and restated credit agreement to refinance indebtedness and provide liquidity for general corporate purposes.
Key Financial Metrics and Debt Structure
The filing details a significant restructuring of the company's credit facilities. As of January 19, 2022, the new 2022 Credit Facility provides an aggregate maximum principal amount of $1,050,000,000. This facility is composed of:
- Senior Unsecured Revolving Credit Facility: $500,000,000 (initial aggregate amount).
- Senior Unsecured Term Loan Facility: $550,000,000 (initial aggregate amount).
- Standby Letters of Credit: Up to $25,000,000 available.
On the effective date of January 19, 2022, the company had $925,900,000 in borrowings outstanding, leaving $124,100,000 available under the facility. The filing does not provide specific revenue, profit, or cash flow metrics for the period.
Material Changes Versus Prior Period
The company terminated its previous $530,000,000 revolving line of credit and term loan credit facility (the 2018 Credit Facilities) and the 2019 Corporate Line of Credit (which had a maximum of $630,000,000). The new 2022 Credit Facility replaces these prior agreements, increasing the total borrowing capacity from $630,000,000 to $1,050,000,000. Additionally, the maturity dates have been extended significantly compared to the expiring 2019 facility:
- Revolving Loans Maturity: January 19, 2026 (extendable for one 12-month period).
- Term Loan Maturity: January 19, 2027 (non-extendable).
The interest rate benchmark has shifted to the Daily Simple Secured Overnight Financing Rate (SOFR) or Term SOFR, replacing previous rate structures.
Guidance, Outlook, and Other Events
Distribution Authorization: On January 20, 2022, the Board of Directors authorized a distribution to Class T and Class I stockholders for January, February, and March 2022. The distribution is set at $0.033333333 per share per month, equating to an annualized rate of $0.40 per share. Payments will be made in cash or via the distribution reinvestment plan.
Covenants and Risks: The new agreement includes standard affirmative and negative covenants, including limitations on debt incurrence and secured recourse indebtedness. Financial covenants include requirements for Consolidated Leverage Ratio, Fixed Charge Coverage Ratio, and Tangible Net Worth. The agreement allows for an incremental increase in borrowing capacity of up to $700,000,000 subject to notice and terms.
Unusual Items: The filing notes that the company assumed obligations under the 2019 Corporate Credit Agreement following a merger with GAHR III in October 2021, which was subsequently refinanced by the 2022 agreement.
Investor Verification Checklist
- Verify the specific terms of the financial covenants (e.g., Consolidated Leverage Ratio thresholds) in the attached Exhibit 10.1.
- Confirm the actual utilization of the $124,100,000 remaining availability under the new facility.
- Review the impact of the SOFR-based interest rate structure on future interest expense compared to prior benchmarks.
- Monitor the company's ability to meet the new financial covenants given the increased debt load of $925.9 million.
- Check for any subsequent filings regarding the incremental increase of up to $700,000,000 in borrowing capacity.